Actively Recruiting
Efficacy and Tolerability of the Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins
Led by Cosmetique Active International · Updated on 2024-07-12
60
Participants Needed
1
Research Sites
15 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this study is to evaluate the efficacy, cosmetic acceptability and improvement of the stigmatization of the tested product (2039125 03) used bis in die (BID) for 3 months in adult patients suffering from mild to moderate melasma, or mild to moderate acne induced post-inflammatory hyperpigmentation, or solar lentigo.
CONDITIONS
Official Title
Efficacy and Tolerability of the Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All skin phototypes
- Presence of only one of the following facial pigmentary conditions: epidermal or mixed mild to moderate melasma; mild to moderate acne-induced post-inflammatory hyperpigmentation; solar lentigo
- Female patients of childbearing potential must use a reliable contraception method and agree not to change it during the study
- Agreement to avoid exposure to natural or artificial ultraviolet radiation during the study
You will not qualify if you...
- Female patients who gave birth less than 3 months before Day 0, who are pregnant, breastfeeding, or plan to become pregnant during the study
- Male patients with beard or facial hair that would interfere with clinical evaluation
- Patients with inflammatory skin conditions of the face such as seborrheic dermatitis or rosacea
- Patients with severe or dermal melasma
- Patients with facial pigmentary disorders other than those listed in inclusion criteria
- Patients who have used topical depigmenting agents (e.g., hydroquinone, glycolic acid, kojic acid, retinoids, azelaic acid, niacinamide) within 1 month prior to Day 0
- Patients who have used systemic treatments such as tranexamic acid or oral melatonin within 1 month prior to Day 0
- Patients who have used drugs that induce pigmentation (e.g., tetracyclines, fluoroquinolones, antiepileptics) within 1 month prior to Day 0
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Medcin Instituto da Pele Ltda
Osasco, Brazil
Actively Recruiting
Research Team
S
Sergio Schalka
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here